Biosimilars Tidal Wave May Well Create A $10 Bill. Opportunity By 2015 For Indian Companies
This article was originally published in The Pink Sheet Daily
Executive Summary
Once the U.S. has regulatory clarity, expected later this year, biologics in development by Indian companies can be valued.